The world economy is changing, and Hungary’s cooperation with China is key to ensuring the future benefits of the next decade, according to Viktor Orbán.
Worries Around Sinopharm Resurface Following Low Antibody Tests
Worries around the Chinese Sinopharm vaccine have resurfaced after insufficient antibody levels were recorded in many people who received both vaccinations in Hungary. While those who defend the vaccine assert that people can still have cell immunity, there is increasing evidence that this is not the case. Those wishing to raise awareness on the issue have joined a Facebook group, sending letters to Prime Minister Viktor Orbán, Chief Medical Officer Cecília Müller, and Hungarian healthcare professionals.
There are more than 3.6 thousand members in the rapidly growing “People Vaccinated with Sinopharm with Negative Laboratory Tests,” closed Facebook group. The purpose of the group is to ensure testing and revaccination if necessary for people who have been vaccinated with the Sinopharm vaccine but have little to no antibodies in their immune system.
Gergely Gulyás shared the number of illnesses and deaths after Hungary's second inoculations, concluding that the numbers support vaccination effectiveness.
The opposition Democratic Coalition turned to the European Commission regarding travel with Covid certificates that fail to show the vaccine type received.